Hematology and Oncology Group

Somerset, New Jersey 08873

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma of Unknown Primary, Pancreatic Cancer

Studies at this site

• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin — Withdrawn before enrolling
• Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed